We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.49B
AUM Growth
+$329M
Cap. Flow
+$1.05B
Cap. Flow %
16.14%
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$112M
2
SWKS icon
Skyworks Solutions
SWKS
+$103M
3
STM icon
STMicroelectronics
STM
+$87.3M
4
ASML icon
ASML
ASML
+$71.6M
5
PANW icon
Palo Alto Networks
PANW
+$64.4M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$169M
2
COO icon
Cooper Companies
COO
+$103M
3
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$102M
4
LRCX icon
Lam Research
LRCX
+$78.9M
5
KLAC icon
KLA
KLAC
+$76.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.94%
2 Technology 31.31%
3 Financials 8.29%
4 Industrials 7.52%
5 Communication Services 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNLI icon
251
Denali Therapeutics
DNLI
$3.65B
$5.33M 0.08%
180,972
-75,706
-29% -$1.98M
BOAC
252
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
$5.32M 0.08%
+537,001
New +$5.31M
CELH icon
253
Celsius Holdings
CELH
$7.47B
$5.32M 0.08%
+244,482
New +$4.71M
SPLK
254
DELISTED
Splunk Inc
SPLK
$5.26M 0.08%
59,479
-368,676
-86% -$40.6M
FIS icon
255
Fidelity National Information Services
FIS
$23.1B
$5.24M 0.08%
+57,153
New +$5.68M
RVMD icon
256
Revolution Medicines
RVMD
$39.9B
$5.14M 0.08%
263,799
-2,067,596
-89% -$40.2M
NVCR icon
257
NovoCure
NVCR
$1.73B
$5.14M 0.08%
+73,925
New +$5.57M
PCRX icon
258
Pacira BioSciences
PCRX
$1.04B
$5.12M 0.08%
87,832
+32
+0% +$2.1K
ZNTL icon
259
Zentalis Pharmaceuticals
ZNTL
$337M
$5.09M 0.08%
181,272
+140,524
+345% +$3.72M
BLSA
260
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$5.08M 0.08%
512,616
– –
LGAC
261
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$5.02M 0.08%
512,450
+162,450
+46% +$1.59M
AXH
262
DELISTED
Industrial Human Capital, Inc.
AXH
$4.91M 0.08%
+489,779
New +$4.91M
KURA icon
263
Kura Oncology
KURA
$800M
$4.91M 0.08%
267,683
– –
FRXB
264
DELISTED
Forest Road Acquisition Corp. II
FRXB
$4.9M 0.08%
500,000
+200,000
+67% +$1.96M
CVII
265
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$4.88M 0.08%
500,000
– –
AAQC
266
DELISTED
Accelerate Acquisition Corp
AAQC
$4.88M 0.08%
500,000
– –
REVHU
267
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$4.88M 0.08%
500,000
– –
SGFY
268
DELISTED
Signify Health, Inc.
SGFY
$4.86M 0.07%
351,786
+8,535
+2% +$120K
IONS icon
269
Ionis Pharmaceuticals
IONS
$8.6B
$4.81M 0.07%
129,908
-62,743
-33% -$2.37M
COCH icon
270
Envoy Medical
COCH
$51.7M
$4.65M 0.07%
475,000
– –
DYN icon
271
Dyne Therapeutics
DYN
$4.7B
$4.58M 0.07%
666,997
-146,142
-18% -$1.01M
AEAE
272
DELISTED
AltEnergy Acquisition Corp
AEAE
$4.47M 0.07%
450,000
+435,000
+2,900% +$4.32M
ACII
273
DELISTED
Atlas Crest Investment Corp. II
ACII
$4.46M 0.07%
+455,000
New +$4.46M
CONX
274
DELISTED
CONX Corp. Class A Common Stock
CONX
$4.45M 0.07%
+450,000
New +$4.45M
BRBR icon
275
BellRing Brands
BRBR
$1.44B
$4.45M 0.07%
178,637
+22,284
+14% +$545K
9 10
11
12 13

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

Woodline Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.

  • Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
  • Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
  • Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
  • Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
  • Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
  • Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.

Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.